Cambridge Investment Research Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $526K | Sell |
19,056
-1,824
| -9% | -$50.3K | ﹤0.01% | 2507 |
|
2025
Q1 | $592K | Sell |
20,880
-2,060
| -9% | -$58.4K | ﹤0.01% | 2267 |
|
2024
Q4 | $954K | Buy |
22,940
+2,064
| +10% | +$85.8K | ﹤0.01% | 1914 |
|
2024
Q3 | $1.4M | Sell |
20,876
-3,574
| -15% | -$239K | ﹤0.01% | 1608 |
|
2024
Q2 | $2.9M | Sell |
24,450
-1,336
| -5% | -$159K | 0.01% | 1051 |
|
2024
Q1 | $2.75M | Buy |
25,786
+2,605
| +11% | +$278K | 0.01% | 1080 |
|
2023
Q4 | $2.31M | Sell |
23,181
-6,329
| -21% | -$629K | 0.01% | 1119 |
|
2023
Q3 | $3.05M | Sell |
29,510
-10,434
| -26% | -$1.08M | 0.01% | 915 |
|
2023
Q2 | $4.85M | Sell |
39,944
-15,927
| -29% | -$1.94M | 0.02% | 678 |
|
2023
Q1 | $8.58M | Buy |
55,871
+14,560
| +35% | +$2.24M | 0.04% | 415 |
|
2022
Q4 | $7.42M | Buy |
41,311
+2,797
| +7% | +$502K | 0.04% | 442 |
|
2022
Q3 | $4.55M | Sell |
38,514
-1,779
| -4% | -$210K | 0.03% | 612 |
|
2022
Q2 | $5.76M | Buy |
40,293
+6,108
| +18% | +$873K | 0.03% | 527 |
|
2022
Q1 | $5.89M | Sell |
34,185
-4,064
| -11% | -$700K | 0.03% | 567 |
|
2021
Q4 | $9.72M | Sell |
38,249
-20,059
| -34% | -$5.09M | 0.04% | 388 |
|
2021
Q3 | $22.4M | Buy |
58,308
+18,296
| +46% | +$7.04M | 0.11% | 189 |
|
2021
Q2 | $9.4M | Sell |
40,012
-11,721
| -23% | -$2.75M | 0.05% | 388 |
|
2021
Q1 | $6.77M | Buy |
51,733
+458
| +0.9% | +$60K | 0.04% | 459 |
|
2020
Q4 | $5.36M | Sell |
51,275
-18,720
| -27% | -$1.96M | 0.03% | 505 |
|
2020
Q3 | $4.95M | Buy |
69,995
+6,255
| +10% | +$443K | 0.03% | 467 |
|
2020
Q2 | $4.09M | Sell |
63,740
-171,556
| -73% | -$11M | 0.03% | 505 |
|
2020
Q1 | $7.05M | Sell |
235,296
-109,295
| -32% | -$3.27M | 0.07% | 272 |
|
2019
Q4 | $6.74M | Sell |
344,591
-49,810
| -13% | -$974K | 0.05% | 363 |
|
2019
Q3 | $6.28M | Buy |
+394,401
| New | +$6.28M | 0.06% | 335 |
|